RxDoctor Payments Data

Troy Barrow, APRN

Psychiatric/Mental Health · Lake Charles, LANPI 1538566336

Payments from drug & device makers

$1,566in general payments, 2019–2025

Across 84 payments — averaging $18.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$485
  • Neurocrine Biosciences, Inc.$296
  • Alkermes, Inc.$152
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$142
  • Teva Pharmaceuticals USA, Inc.$132
  • Johnson & Johnson$82
  • plus $277 from 7 others

What the payments were for

  • Food & beverage$1,566100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,566 in reported general payments places this provider in the 55th percentile of 615 psychiatric/mental health providers in Louisiana.

See all psychiatric/mental health providers in Louisiana

Medicare billing

Part B allowed, 2024
$7,347
Medicare patients
59
Services billed
148

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate54$176,721
AustedoDeutetrabenazine15$113,888
VraylarCariprazine Hcl27$38,464
TrintellixVortioxetine Hydrobromide12$12,225
Paliperidone ErPaliperidone37$5,070
Divalproex Sodium ErDivalproex Sodium75$4,821
Aripiprazole119$4,693
Lisdexamfetamine Dimesylate17$3,714
Desvenlafaxine Succinate ErDesvenlafaxine Succinate11$2,724
Risperidone104$2,271
Oxcarbazepine67$1,940
Haloperidol60$1,936
Escitalopram Oxalate31$1,673
Quetiapine Fumarate121$1,608
Trazodone Hcl227$1,551

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$82$176,72154 claims
Teva Pharmaceuticals USA, Inc.Austedo$132$113,88815 claims
AbbVieVraylar$485$38,46427 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 615 psychiatric/mental health providers in Louisiana.

Other psychiatric/mental health in Lake Charles

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →